(CELH) Celsius Holdings - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US15118V2079

Stock:

Total Rating 40

Risk 40

Buy Signal 0.22

Beverages - Non-Alcoholic +8.0
Soft Drinks & Non-alcoholic Beverages +10.9

Market Cap: 12,456m
Avg Trading Vol: 219M USD

ATR: 4.40%
Peers RS (IBD): 63.64

Risk 5d forecast
Volatility	60.2%
Relative Tail Risk	-14.5%

Reward TTM
Sharpe Ratio	1.37
Alpha	42.85

Character TTM
Beta	1.079
Beta Downside	0.429

Drawdowns 3y
Max DD	77.86%
CAGR/Max DD	0.25

EPS (Earnings per Share)

EPS CAGR: -0.90%
EPS Trend: 29.9%

Last SUE: -3.57
Qual. Beats: 0

Revenue

Rev. CAGR: 67.73%
Rev. Trend: 89.5%

Last SUE: 0.26
Qual. Beats: 0

Risks

Fundamental:

P/E ratio: 402.6667

Description: CELH Celsius Holdings

Celsius Holdings, Inc. develops, processes, manufactures, markets, sells, and distributes functional energy drinks in the United States, North America, Europe, the Asia Pacific, and internationally. The company offers CELSIUS, a lifestyle and energy drink; CELSIUS Originals and Vibe, which are functional energy drinks in various flavors that is offered in carbonated and non-carbonated forms; CELSIUS ESSENTIALS, a functional energy drink formulated with aminos; CELSIUS On-the-Go Powder, a functional energy drink in powder form; and CELSIUS Hydration, a line of zero-sugar hydration powders infused electrolytes in various fruit-forward flavors, as well as CELSIUS ready-to-drink products. It distributes its products through direct-to-store delivery, independent distributors, supermarkets, convenience stores, drug stores, nutritional stores, food service providers, and mass merchants, as well as natural food stores, fitness centers, mass market retailers, vitamin specialty stores, club stores, gyms, and e-commerce platforms. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income: 64.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.01 > 1.0
NWC/Revenue: 42.93% < 20% (prev 78.35%; Δ -35.42% < -1%)
CFO/TA 0.11 > 3% & CFO 554.6m > Net Income 64.4m
Net Debt (55.5m) to EBITDA (129.6m): 0.43 < 3
Current Ratio: 1.89 > 1.5 & < 3
Outstanding Shares: last quarter (237.2m) vs 12m ago 1.49% < -2%
Gross Margin: 51.38% > 18% (prev 0.50%; Δ 5088 % > 0.5%)
Asset Turnover: 61.00% > 50% (prev 80.43%; Δ -19.44% > 0%)
Interest Coverage Ratio: 2.94 > 6 (EBITDA TTM 129.6m / Interest Expense TTM 36.3m)

Altman Z'' 1.52

A: 0.17 (Total Current Assets 1.94b - Total Current Liabilities 1.03b) / Total Assets 5.27b
B: 0.03 (Retained Earnings 165.5m / Total Assets 5.27b)
C: 0.03 (EBIT TTM 106.7m / Avg Total Assets 3.49b)
D: 0.07 (Book Value of Equity 168.1m / Total Liabilities 2.30b)
Altman-Z'' Score: 1.52 = BB

Beneish M -0.78

DSRI: 1.58 (Receivables 513.7m/209.8m, Revenue 2.13b/1.37b)
GMI: 0.97 (GM 51.38% / 49.59%)
AQI: 3.54 (AQ_t 0.62 / AQ_t-1 0.17)
SGI: 1.55 (Revenue 2.13b / 1.37b)
TATA: -0.09 (NI 64.4m - CFO 554.6m) / TA 5.27b)
Beneish M-Score: -0.78 (Cap -4..+1) = D

What is the price of CELH shares?

As of February 26, 2026, the stock is trading at USD 50.61 with a total of 5,601,187 shares traded.
Over the past week, the price has changed by +16.53%, over one month by -7.21%, over three months by +25.27% and over the past year by +88.28%.

Is CELH a buy, sell or hold?

Celsius Holdings has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CELH.

StrongBuy: 8
Buy: 6
Hold: 6
Sell: 1
StrongSell: 0

What are the forecasts/targets for the CELH price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	64	26.5%
Analysts Target Price	64	26.5%

CELH Fundamental Data Overview February 24, 2026

P/E Trailing = 402.6667
P/E Forward = 39.8406
P/S = 5.8594
P/B = 10.3533
P/EG = 0.966
Revenue TTM = 2.13b USD
EBIT TTM = 106.7m USD
EBITDA TTM = 129.6m USD
Long Term Debt = 861.5m USD (from longTermDebt, last quarter)
Short Term Debt = 3.37m USD (from shortTermDebt, last fiscal year)
Debt = 861.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 55.5m USD (from netDebt column, last quarter)
Enterprise Value = 12.51b USD (12.46b + Debt 861.5m - CCE 806.0m)
Interest Coverage Ratio = 2.94 (Ebit TTM 106.7m / Interest Expense TTM 36.3m)
EV/FCF = 23.90x (Enterprise Value 12.51b / FCF TTM 523.6m)
FCF Yield = 4.18% (FCF TTM 523.6m / Enterprise Value 12.51b)
FCF Margin = 24.63% (FCF TTM 523.6m / Revenue TTM 2.13b)
Net Margin = 3.03% (Net Income TTM 64.4m / Revenue TTM 2.13b)
Gross Margin = 51.38% ((Revenue TTM 2.13b - Cost of Revenue TTM 1.03b) / Revenue TTM)
Gross Margin QoQ = 51.34% (prev 51.52%)
Tobins Q-Ratio = 2.38 (Enterprise Value 12.51b / Total Assets 5.27b)
Interest Expense / Debt = 2.12% (Interest Expense 18.2m / Debt 861.5m)
Taxrate = 25.62% (50.0m / 195.1m)
NOPAT = 79.4m (EBIT 106.7m * (1 - 25.62%))
Current Ratio = 1.89 (Total Current Assets 1.94b / Total Current Liabilities 1.03b)
Debt / Equity = 0.29 (Debt 861.5m / totalStockholderEquity, last quarter 2.96b)
Debt / EBITDA = 0.43 (Net Debt 55.5m / EBITDA 129.6m)
Debt / FCF = 0.11 (Net Debt 55.5m / FCF TTM 523.6m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.85% (Net Income 64.4m / Total Assets 5.27b)
RoE = 3.41% (Net Income TTM 64.4m / Total Stockholder Equity 1.89b)
RoCE = 3.88% (EBIT 106.7m / Capital Employed (Equity 1.89b + L.T.Debt 861.5m))
RoIC = 6.30% (NOPAT 79.4m / Invested Capital 1.26b)
WACC = 9.35% (E(12.46b)/V(13.32b) * Re(9.89%) + D(861.5m)/V(13.32b) * Rd(2.12%) * (1-Tc(0.26)))
Discount Rate = 9.89% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.15%
[DCF] Terminal Value 74.03% ; FCFF base≈382.0m ; Y1≈399.2m ; Y5≈461.4m
[DCF] Fair Price = 24.45 (EV 6.36b - Net Debt 55.5m = Equity 6.30b / Shares 257.8m; r=9.35% [WACC]; 5y FCF grow 4.81% → 2.90% )
EPS Correlation: 29.89 | EPS CAGR: -0.90% | SUE: -3.57 | # QB: 0
Revenue Correlation: 89.47 | Revenue CAGR: 67.73% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.28 | Chg7d=+0.000 | Chg30d=-0.003 | Revisions Net=-1 | Analysts=11
EPS next Year (2026-12-31): EPS=1.55 | Chg7d=+0.000 | Chg30d=-0.001 | Revisions Net=-2 | Growth EPS=+22.2% | Growth Revenue=+32.2%
[Analyst] Revisions Ratio: -0.20 (2 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.6% (Discount Rate 9.9% - Earnings Yield 0.2%)
[Growth] Growth Spread = +105.2% (Analyst 114.9% - Implied 9.6%)

Additional Sources for CELH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle